Neurocrine Biosciences Stock Price. Everything You Need To Know About The Neurocrine Biosciences Stock!
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is focused on discovering and developing pharmaceuticals for the treatment of neurological, endocrine and psychiatric-based diseases and disorders. Its portfolio includes treatments for tardive dyskinesia, Parkinson’s disease, endometriosis and uterine fibroids. Its product pipeline includes INGREZZA (valbenazine), which provides a once-daily dosing treatment option for tardive dyskinesia and has three dosing options (40 milligrams (mg), 60 mg and 80 mg capsules); ONGENTYS (opicapone) is an adjunctive therapy to levodopa/carbidopa in patients with Parkinson’s disease; ORILISSA (elagolix) is used for the management of moderate to severe endometriosis pain in women. Its pipeline also includes DYSVAL (valbenazine), ORIAHNN (elagolix, estradiol, and norethindrone acetate and elagolix capsules), ALKINDI/ALKINDI SPRINKLE (hydrocortisone), and EFMODY (hydrocortisone modified-release hard capsules).
Neurocrine Biosciences Stock Price. Everything You Need To Know About The Neurocrine Biosciences Stock! performance
- Employees 1200
- Company HQ San Diego
- Website https://www.neurocrine.com/
- NBIX Asset Type Common Stock
- NBIX Market Capitalization 13.7B
- Earnings Per Share 2.48
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0.648
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in promising stocks? Look no further than Neurocrine Biosciences. As an expert in the field, Zorion is excited to recommend this stock to help you make informed investment decisions. Neurocrine Biosciences is a renowned biopharmaceutical company known for its focus on neurological and endocrine-related diseases. With a solid track record of innovative research and development, investing in Neurocrine Biosciences can be a lucrative opportunity. Our investment insights and recommendations, specifically tailored for investors from Malaysia, Thailand, Indonesia, and Vietnam, will guide you towards making wise investment choices. Visit Zorion today to access resources and educational materials to further enhance your investment knowledge.
